S9624 Ifosfamide in Treating Patients With Meningeal Tumors
Status:
Terminated
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with
meningeal tumors that have recurred or that cannot be removed surgically.
Phase:
Phase 2
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)